Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...

Among cancer survivors, excess body weight is associated with an increased risk for a second primary malignant neoplasm, ...

September is Childhood Cancer Awareness Month. It's an opportunity to not only talk about it but also learn of ways to help ...

CHICAGO -- The non-hormonal drug elinzanetant reduced the frequency of moderate-to-severe hot flashes in postmenopausal women ...

Human papillomavirus (HPV) and hyperactivated YAP1 form a YAP1-HPV oncogenic alliance to drive the malignant transformation ...

Conditions managed were coded using the International Classification of Primary Care Version 2 PLUS (ICPC-2 PLUS)12 which is automatically classified to ICPC-2.12 We selected seven skin cancer-related ...

Cetuximab biosimilar is under clinical development by Alkem Laboratories and currently in Phase III for Pharyngeal Neoplasm.

Cetuximab biosimilar is under clinical development by Alkem Laboratories and currently in Phase III for Lip Cancer.

This can happen in any part of the body. You might hear the term "cervical dysplasia" following a Pap test. Or "hip dysplasia" following imaging tests on an infant or young child. Dysplasia isn't ...

研究结果显示，脑恶性肿瘤（Malignant Neoplasm of the Brain）随着手机使用时间、累计通话时间或累计通话次数的增加， 风险并未明显增加 ；无绳电话的使用与脑胶质瘤、脑膜瘤或听神经瘤的风险 无显著相关性 ...

(f) SM: Clusters of epithelial cells including scattered mucin-filled cells, suspicious for neoplasm. Overall cellularity was low. Follow-up surgical specimen showed low-grade mucoepidermoid ...